16 February 2026
16 February 2026
The European Life Sciences Coalition (ELSC) aims to mobilise public and private investment amid concerns for the sector’s flagging funding landscape.
The AURORA and BEACON studies demonstrated that bitopertin significantly reduces whole blood metal-free PPIX.
The ABPI says that industry and academia must come together to bridge the gap between academic and commercially ready preclinical models.
Immunic will issue 229.1 million pre-funded warrants at $0.873 each to select investors, raising upfront proceeds of $200m.
As pain is such a heterogeneous indication, significant opportunities remain for a variety of different and more effective non-opioid treatment options to be developed.
The decision by the EC was supported by data from the Myasthenia Gravis Inebilizumab Trial.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
